Xenetic Biosciences annual depreciation and amortization
2012
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Xenetic Biosciences Depreciation & Amortization Growth & History (XBIO)
Xenetic Biosciences's depreciation and amortization was $0 for fiscal 2023.
View full Xenetic Biosciences company overviewXenetic Biosciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | −$1,000 | — |
| 2020 | 2020-12-31 | $1,000 | −$3,199 | −76.18% |
| 2019 | 2019-12-31 | $4,199 | −$11,628 | −73.47% |
| 2018 | 2018-12-31 | $15,827 | −$7,957 | −33.46% |
| 2017 | 2017-12-31 | $23,784 | −$12,665 | −34.75% |
| 2016 | 2016-12-31 | $36,449 | −$19,666 | −35.05% |
| 2015 | 2015-12-31 | $56,115 | −$32,574 | −36.73% |
| 2014 | 2014-12-31 | $88,689 | $36,657 | +70.45% |
| 2013 · Dec 31 | 2013-12-31 | $52,032 | −$52,587 | −50.27% |
| 2012 · Dec 31 | 2012-12-31 | $104,619 | — | — |
| 2012 · Aug 31 | 2012-08-31 | $19,481 | — | — |
Xenetic Biosciences quarterly depreciation and amortization
Q1.12
Q2.12
Q3.12
Q1.13
Q1.13
Q1.13
Q2.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q3 2021 | 2021-09-30 | $0 | $0 | — |
| Q2 2021 | 2021-06-30 | $0 | −$200 | — |
| Q1 2021 | 2021-03-31 | $0 | −$591 | — |
| Q3 2020 | 2020-09-30 | $0 | −$7,450 | — |
| Q2 2020 | 2020-06-30 | $200 | −$800 | −80.00% |
| Q1 2020 | 2020-03-31 | $591 | −$867 | −59.47% |
| Q3 2019 | 2019-09-30 | $7,450 | $6,450 | +645.00% |
| Q2 2019 | 2019-06-30 | $1,000 | −$4,000 | −80.00% |
| Q1 2019 | 2019-03-31 | $1,458 | −$4,265 | −74.52% |
| Q3 2018 | 2018-09-30 | $1,000 | −$4,000 | −80.00% |
| Q2 2018 | 2018-06-30 | $5,000 | −$1,000 | −16.67% |
| Q1 2018 | 2018-03-31 | $5,723 | −$1,989 | −25.79% |
| Q3 2017 | 2017-09-30 | $5,000 | −$4,082 | −44.95% |
| Q2 2017 | 2017-06-30 | $6,000 | −$3,082 | −33.94% |
| Q1 2017 | 2017-03-31 | $7,712 | −$1,370 | −15.08% |
| Q3 2016 | 2016-09-30 | $9,082 | $438 | +5.07% |
| Q2 2016 | 2016-06-30 | $9,082 | $531 | +6.21% |
| Q1 2016 | 2016-03-31 | $9,082 | −$154,207 | −94.44% |
| Q3 2015 | 2015-09-30 | $8,644 | −$15,720 | −64.52% |
| Q2 2015 | 2015-06-30 | $8,551 | −$10,204 | −54.41% |
| Q1 2015 | 2015-03-31 | $163,289 | $147,300 | +921.26% |
| Q3 2014 | 2014-09-30 | $24,364 | $13,270 | +119.61% |
| Q2 2014 | 2014-06-30 | $18,755 | $6,892 | +58.10% |
| Q1 2014 · Mar 31 | 2014-03-31 | $15,989 | $332 | +2.12% |
| Q3 2013 | 2013-09-30 | $11,094 | — | — |
| Q2 2013 · Jun 30 | 2013-06-30 | $11,863 | — | — |
| Q2 2013 · May 31 | 2013-05-31 | $5,313 | $0 | 0.00% |
| Q1 2013 · Mar 31 | 2013-03-31 | $15,657 | — | — |
| Q1 2013 · Feb 28 | 2013-02-28 | $5,313 | $0 | 0.00% |
| Q1 2013 · Nov 30 | 2012-11-30 | $5,313 | $1,771 | +50.00% |
| Q3 2012 | 2012-05-31 | $5,313 | — | — |
| Q2 2012 | 2012-02-29 | $5,313 | — | — |
| Q1 2012 | 2011-11-30 | $3,542 | — | — |
Xenetic Biosciences depreciation and amortization trends
Over the last five fiscal years, Xenetic Biosciences's depreciation and amortization decreased from $15,827 to $0, a change of −$15,827. The latest reported quarter, Q3 2021, shows $0.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Xenetic Biosciences source filings ↗